Published in Acta Cardiol on January 01, 1982
Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace (1999) 1.76
Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol (1999) 1.68
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J (2002) 1.59
Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J (1998) 1.58
The same molecular mechanism at the maternal meiosis I produces mono- and dicentric 8p duplications. Am J Hum Genet (1996) 1.53
Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace (2010) 1.43
Resistance to activated protein C mimicking dysfunctional protein C: diagnostic approach. Blood Coagul Fibrinolysis (1996) 1.39
Systemic acute-phase response after laparoscopic and open cholecystectomy. Surg Endosc (2001) 1.30
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res (2001) 1.26
Second malignancies in Hodgkin's disease: a complication of certain forms of treatment. Br Med J (1980) 1.19
Primary malignant neoplasms associated with chronic lymphocytic leukemia. Tumori (1980) 1.14
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. Blood (1982) 1.07
Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. J Clin Pathol (1991) 1.06
Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates. Lancet (1976) 1.05
CT and MRI of Wernicke's encephalopathy. Radiol Med (2011) 1.01
Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women. Reproduccion (1983) 1.00
Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab (2000) 0.98
Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells. J Biol Chem (2001) 0.97
Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost (1993) 0.93
Ovulation-inhibiting properties of Org OD 14. Reproduccion (1983) 0.91
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2000) 0.90
New DNAH11 mutations in primary ciliary dyskinesia with normal axonemal ultrastructure. Eur Respir J (2010) 0.89
Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty. Pacing Clin Electrophysiol (1996) 0.89
Different effects of atrial and C-type natriuretic peptide on the urinary excretion of endothelin-1 in man. Clin Sci (Lond) (1998) 0.88
Autonomic regulation of heart rate and QT interval in nonalcoholic cirrhosis with ascites. Digestion (1997) 0.87
An unusual case of non secretory multiple myeloma with intracellular lambda chains. Haematologica (1981) 0.87
In vivo evidence that endogenous dopamine modulates sympathetic activity in man. Hypertension (1999) 0.87
Critical review of dilatation and curettage in the diagnosis of malignant pathology of the endometrium. Eur J Gynaecol Oncol (1986) 0.87
Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease. Dig Liver Dis (2003) 0.86
Prevalence of pain in elderly hospitalized patients. Arch Gerontol Geriatr (2009) 0.85
Atrioventricular interval optimization in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements. Pacing Clin Electrophysiol (2000) 0.85
Plasma tryptophan and anorexia in human cancer. Eur J Cancer Clin Oncol (1986) 0.85
Asymptomatic homozygous protein C deficiency. Acta Haematol (1990) 0.85
Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab (1994) 0.85
The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood (1997) 0.84
A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer. Eur J Cancer (1997) 0.84
Anophthalmos with limb anomalies (Waardenburg opththalmo-acromelic syndrome): report of a new Italian case with renal anomaly and review. Genet Couns (2006) 0.84
A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy. Maturitas (1980) 0.84
Port site metastasis after laparoscopy for uterine cervical carcinoma. Surg Endosc (2003) 0.83
Should stimulation therapy for congestive heart failure be combined with defibrillation backup? Am J Cardiol (2000) 0.83
Cardiovascular function in pregnancy: effects of posture. BJOG (2001) 0.83
Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia. Eur J Neurol (2011) 0.83
Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympathetic-adrenal discharge in humans. J Clin Endocrinol Metab (1988) 0.83
Dopamine and sympathoadrenal activity in man. Clin Exp Hypertens (1997) 0.83
Acute effects of physiological increments of brain natriuretic peptide in humans. Hypertension (1995) 0.83
Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients. Clin Nutr (1991) 0.82
Intrarticular methotrexate in the therapy of rheumatoid arthritis. Recenti Prog Med (1989) 0.82
Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1996) 0.82
Relationship between age and anterograde refractoriness of the accessory pathway in Wolff-Parkinson-White patients. Cardiology (1989) 0.82
Increased plasma free tryptophan levels in human cancer: a tumor related effect? Anticancer Res (1991) 0.81
Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism. J Thromb Haemost (2012) 0.81
Immunologic and clinical investigation on a bovine thymic extract. Therapeutic applications in primary immunoedificiencies. Pediatr Res (1979) 0.81
22q11.2 Distal Deletion Syndrome: Description of a New Case with Truncus Arteriosus Type 2 and Review. Mol Syndromol (2011) 0.81
Clinical staging and therapeutic results in multiple myeloma. Eur J Cancer Clin Oncol (1983) 0.81
Preliminary experience with the pH-triggered pacemaker. Pacing Clin Electrophysiol (1978) 0.81
Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia. Eur Respir J (2011) 0.81
The non-producer plasma cell myeloma. Report of a case and review of the literature. Blut (1986) 0.80
The subjective feeling of burden in caregivers of elderly with dementia: how to intervene? Arch Gerontol Geriatr (2009) 0.80
The JAK2 V617F mutation in patients with cerebral venous thrombosis. J Thromb Haemost (2012) 0.80
Chronic neutrophilic leukemia and myeloma. Report on long survival. Tumori (1984) 0.80
Aging and atrial electrophysiologic properties in man. Int J Cardiol (1984) 0.80
Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene. Thromb Haemost (1998) 0.80
Mapping the organization of atrial fibrillation with basket catheters. Part I: Validation of a real-time algorithm. Pacing Clin Electrophysiol (2001) 0.80
Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma. Thromb Haemost (1991) 0.80
Parental mosaicism in de novo translocation (21q21q) Down's syndrome. J Med Genet (1991) 0.80
Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. Am J Hypertens (1995) 0.79
Guiding principles in choosing a therapeutic table for DCI hyperbaric therapy. Minerva Anestesiol (2009) 0.79
Atrial fibrillation in athletes. Int J Sports Med (2012) 0.79
Hypereosinophilic syndrome and plasmocytoma. Report of a case and review of the literature. Acta Haematol (1984) 0.79
[Evaluation of sinoatrial conduction time by recording the sinus node potential. Comparison with indirect methods of evaluation]. Arch Mal Coeur Vaiss (1982) 0.79
Recurrent patterns of atrial depolarization during atrial fibrillation assessed by recurrence plot quantification. Ann Biomed Eng (2000) 0.79
Liver abnormalities and portal hypertension in Ullrich-Turner syndrome. Am J Med Genet (1998) 0.79
Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. J Endocrinol Invest (1981) 0.79
Automated classification of human atrial fibrillation from intraatrial electrograms. Pacing Clin Electrophysiol (2000) 0.79
Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice. Eur J Cancer (1995) 0.78
Letter: Severe combined immuno-deficiency and trisomy D. Arch Dis Child (1976) 0.78
Parallel increase in carotid, brachial and left ventricular cross-sectional areas in arterial hypertension. J Hum Hypertens (1997) 0.78
Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden). Blood (1999) 0.78
Activity of ruboxyl, a nitroxyl derivative of daunorubicin, on experimental models of colorectal cancer metastases. Tumour Biol (1999) 0.78
Measure of synchronisation of right atrial depolarisation wavefronts during atrial fibrillation. Med Biol Eng Comput (2002) 0.78
Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report. Thromb Haemost (1998) 0.78
Content and release of beta-thromboglobulin and platelet factor 4 in patients with qualitative platelet defects. Thromb Res (1979) 0.78
Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage. J Thromb Haemost (2012) 0.78
24-hour heart rate variability in patients with vasovagal syncope. Pacing Clin Electrophysiol (2000) 0.78
Treatment of complicated benign prostatic hyperplasia with LHRH-analogues in aged patients. Int J Androl (1989) 0.78
Effects of low-dose adrenomedullin on cardiac function and systemic haemodynamics in man. Clin Physiol (2000) 0.78
Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch. J Interv Card Electrophysiol (2000) 0.78
The effects of atropine on sinoatrial conduction time directly measured from sinus node electrogram. A comparison with results furnished by indirect methods. Eur Heart J (1984) 0.78
Effects of atropine on atrial refractoriness and its dispersion in humans. Int J Clin Pharmacol Ther Toxicol (1984) 0.77
Author reply to: can transthoracic echocardiography be used as a reference method for cardiac output measurement? Minerva Anestesiol (2013) 0.77
[Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension]. G Ital Cardiol (1992) 0.77